アンチフォスフォリピド抗体と血栓形成
1Department of Medicine and Therapeutics, Foresterhill, Aberdeen, UK. m.greaves@abdn.ac.uk
Lancet (London, England)
|April 28, 1999
まとめ
アンチフォスフォリピド抗体は,血栓や妊娠中絶のリスクを示します. アンチフォスフォリピド症候群の特定は,再発性血栓症の管理と抗血栓治療のガイドに不可欠です.
科学分野:
- 免疫学 免疫学とは
- 血液学 ヘマトロジ
- 産科は産婦人科です.
背景:
- アンチフォスフォリピド抗体は,血栓形成,再発性妊娠中絶,および血栓塞車症に関連しています.
- これらの抗体は,抗リンパ脂症候群 (APS) の重要な検査用マーカーとして機能します.
研究 の 目的:
- 再発性血栓形成のリスクによるAPSを特定することの臨床的重要性を強調する.
- 多くのAPS症例において抗血栓治療の必要性を強調するために.
主な方法:
- APS.の臨床関連および検査マーカーのレビュー.
- 診断上の課題と治療の限界の分析.
主要な成果:
- APSの識別は,再発性血栓性イベントの管理に不可欠です.
- 有効な抗血栓治療は,しばしばAPS患者のために必要である.
結論:
- APSの診断と管理は,さまざまな臨床的特徴によって複雑になります.
- 現在の抗体検査の限界と,エビデンスに基づくガイドラインの欠如は,最適な患者ケアを妨げています.
関連する概念動画
Inflammation
Overview
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...


